| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/11/2009 | WO2009088939A3 Compositions and methods for treating neurodegenerative diseases |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227672 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227653 Substituted gamma lactams as therapeutic agents |
| 09/10/2009 | US20090227649 Management of Ophthalmologic Disorders, Including Macular Degeneration |
| 09/10/2009 | US20090227636 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension |
| 09/10/2009 | US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 09/10/2009 | US20090227573 Substituted cyclopentanes having prostaglandin activity |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227488 Class of bioactive glycoprotein |
| 09/10/2009 | US20090226547 Dietary Supplement For Eye Health |
| 09/10/2009 | US20090226531 Methods and composition for intraocular delivery of therapeutic sirna |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/09/2009 | EP2097455A2 Humanized anti-factor d antibodies |
| 09/09/2009 | EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 09/09/2009 | EP2097107A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 09/09/2009 | EP2097086A2 Contact lens compositions |
| 09/09/2009 | EP1858533A4 Use of amniotic fluid (af) in treating ocular disease and injury |
| 09/09/2009 | EP1681059B1 Pharmaceutical composition containing prostaglandin |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | CN101524394A Quezui tea preparation and application thereof |
| 09/09/2009 | CN101524360A Azithromycin eye-drops new composition and preparation method and application thereof |
| 09/09/2009 | CN101524351A Treating infectious diseases by administering an ICE inhibitor |
| 09/09/2009 | CN101524347A Intraocular implant for preventing and treating after cataract and preparation method thereof |
| 09/09/2009 | CN100537574C Preventive or therapeutic agent for diabetic maculopathy |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536916C Novel usage of human antalzyme in the process for preparing ophthalmopathy treating medicine |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585659 Carotene synthase gene and uses therefor |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2355466C Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009108577A2 Use of black soybean for treating ophthalmic diseases |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009107759A1 Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder |
| 09/03/2009 | WO2009107753A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 09/03/2009 | WO2009107652A1 Agent for enhancing corneal epithelial barrier function |
| 09/03/2009 | WO2009107380A1 Anti-allergic agent |
| 09/03/2009 | WO2009106850A1 Anti-oxidants for use for the treatment of damage to bodily tissue |
| 09/03/2009 | WO2009106767A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor |
| 09/03/2009 | WO2009020848A3 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 09/03/2009 | US20090221642 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof-176 |
| 09/03/2009 | US20090221585 Novel compounds and their use related to compositions for treating disease |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090220618 Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
| 09/03/2009 | US20090220592 Preparation for the treatment of tinnitus |
| 09/03/2009 | US20090220573 Method, Device, and System for Delivery of Therapeutic Agents to the Eye |
| 09/03/2009 | US20090220572 Injectable Combination Therapy for Eye Disorders |
| 09/03/2009 | US20090220571 Self-expanding devices and methods therefor |
| 09/03/2009 | US20090220504 Combinatorial therapy |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2729129A1 Use of black soybean for treating ophthalmic diseases |
| 09/03/2009 | CA2717133A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 09/03/2009 | CA2716466A1 Prophylactic or therapeutic agent for eye disease accompanied by optic nerve disorder |
| 09/03/2009 | CA2716418A1 Agent for enhancing corneal epithelial barrier function |
| 09/03/2009 | CA2716397A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 09/03/2009 | CA2714721A1 Anti-allergic agent |
| 09/03/2009 | CA2711866A1 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096105A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
| 09/02/2009 | EP2094678A2 Prostaglandin prodrugs as ocular hypotensive agents |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094287A1 Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye |
| 09/02/2009 | EP2094281A2 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 09/02/2009 | EP2094252A1 Nutritional supplement composition for treatment of ocular diseases |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | EP1761254B1 Improvement of image quality in the eye |
| 09/02/2009 | EP1744759B1 Use of loteprednol etabonate for the treatment of dry eye |
| 09/02/2009 | EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1423115B9 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1326584B1 Delivery system and method of treating or preventing otitis media |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518649A Compound preparation for treating ophthalmic infection and inflammation |
| 09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518547A Ophthalmic preparation combination containing deproteinised calf blood extract |
| 09/02/2009 | CN101518537A Preventives/remedies for inflammatory airway diseases |
| 09/02/2009 | CN101518511A Method for preparing ophthalmic preparation containing tacrolimus |
| 09/02/2009 | CN101518483A Biological vision assisting system |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534428C Application of haematopophyrin in treating ophthalmic disease |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582451 Carotene synthase gene and uses therefor |